![[Table] KOSPI Index Futures/Options Price Table (13th)-1](/api/img?u=https%3A%2F%2Fr.yna.co.kr%2Fglobal%2Fhome%2Fv01%2Fimg%2Fyonhapnews_logo_1200x800_kr01.jpg&w=1200&q=72&f=webp)
As of 3:45 p.m., KOSPI 200 and KOSPI 200 futures market price status, opening price, closing price, change compared to the previous day, and trading volume for each item.
AI-generated summary
Provides price and trading volume data for the stock index futures market as of 3:45 p.m.
◇Stock index futures
(Unit: points, contract)
Stock name Open price Closing price Trading volume compared to previous day KOSPI 200 972.51 942.07 -62.85 147897 KOSPI 200 F 202612 978.90 944.80 -63.45 180508 KOSPI 200 F 202703 965.00 931.00 -66.15 160 KOSPI200 F 202706 970.00 935.00 -70.00 16 KOSPI200 F 202709 0.00 1028.20 0.00 0 KOSPI200 F 202712 952.85 952.85 -82.85 1 KOSPI200 F 202806 0.00 1050.30 0.00 0 KOSPI200 F 202812 0.00 1067.45 0.00 0
※ As of 3:45 p.m.
(Data = KRX, Yonhap Infomax)

While foreign investors have recorded a large-scale net selling of over 200 trillion won in the stock market since the beginning of the year, they have consistently made net purchases of over 9 trillion won in the exchange-traded fund (ETF) market.

A welcoming event was held in Busan on the 13th for the Panstar Acro, the first domestic container ship to complete a trial run on the Arctic route. Minister of Oceans and Fisheries Hwang Jong-woo announced plans to expand operations next year and review the possibility of the Northwest Passage.

While KOSPI fell sharply on the 13th due to large-scale selling by foreigners and a supply-demand gap caused by the end of share buybacks, the heads of major domestic securities companies diagnosed that the decline due to investor sentiment and external uncertainty was excessive even though the fundamentals of semiconductor companies were solid.

Novo Nordisk has applied for national health insurance reimbursement of its obesity drug Wegovy in South Korea to counter Eli Lilly's dominant Mounjaro and prepare for the launch of Hanmi Pharmaceutical's homegrown rival Eppe, which could reshape the country's GLP-1 weight-loss drug market.

Due to the decline in U.S. semiconductor stocks, concerns about AI infrastructure investment, and intensifying competition among Chinese memory manufacturers, the Nikkei 225 index on the Tokyo Stock Exchange recorded 67,551.35 on the 13th, down 2.14% from the previous trading day, and AI and semiconductor stocks such as Advantest and Softbank Group showed a selling trend.

The KOSPI 200 Volatility Index (VKOSPI), a Korean-style fear index, soared more than 23% on the 13th, causing the KOSPI index to drop 6.39% to 5,976.34, and the market capitalization fell to the 4 trillion won range in two and a half months. The sharp decline of Samsung Electronics and SK Hynix had an impact, and foreign selling continues.